Tompkins Financial’s Exelixis EXEL Stock Holding History

Tompkins Financial’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21	Closed	–	–	454
2020 Q4	$0	Buy	+21	New	+$440	﹤0.01%	544

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Tompkins Financial's EXEL Position: Q1 2021 in Review

Tompkins Financial sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 21 shares.

Tompkins Financial first reported a position in EXEL in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 347 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

Tompkins Financial reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
Tompkins Financial sold 21 Exelixis shares in Q1 2021.
Tompkins Financial first reported a position in Exelixis in Q4 2020 and held it in 1 quarter.
Tompkins Financial's Exelixis position peaked at $0 in Q4 2020.
347 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on Tompkins Financial's 13F filing for Q1 2021, filed 9 Jun 2021.